Medtronic Shares Selling Off Despite Inline Q3 Results, Narrowed FY Outlook

By: via Benzinga
Medtronic, (NYSE: MDT ) announced its third quarter of fiscal year 2014 earnings on Tuesday morning. Shares are down more than 2 percent to around $55.55 at last check. Revenue grew 4 percent on constant currency basis to $4.2 billion, slightly higher than the $4.15 billion analyst estimates. GAAP
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.